Country Trust Bank’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.5K | Hold |
235
| – | – | ﹤0.01% | 321 |
|
|
2026
Q1 | $14.3K | Hold |
235
| – | – | ﹤0.01% | 292 |
|
|
2025
Q4 | $12.7K | Sell |
235
-5
| -2% | -$241 | ﹤0.01% | 301 |
|
|
2025
Q3 | $10.8K | Buy |
240
+5
| +2% | +$234 | ﹤0.01% | 323 |
|
|
2025
Q2 | $10.9K | Buy |
+235
| New | +$11.5K | ﹤0.01% | 300 |
|
|
2023
Q4 | – | Sell |
-225
| Closed | -$13.1K | – | 337 |
|
|
2023
Q3 | $13.1K | Buy |
+225
| New | +$13.8K | ﹤0.01% | 230 |
|
|
2023
Q2 | – | Sell |
-240
| Closed | -$16.6K | – | 305 |
|
|
2023
Q1 | $16.6K | Buy |
+240
| New | +$16.9K | ﹤0.01% | 215 |
|
|
2022
Q4 | – | Sell |
-68
| Closed | -$5K | – | 324 |
|
|
2022
Q3 | $5K | Hold |
68
| – | – | ﹤0.01% | 310 |
|
|
2022
Q2 | $5K | Hold |
68
| – | – | ﹤0.01% | 312 |
|
|
2022
Q1 | $5K | Sell |
68
-67
| -50% | -$4.5K | ﹤0.01% | 346 |
|
|
2021
Q4 | $8K | Buy |
135
+67
| +99% | +$3.93K | ﹤0.01% | 351 |
|
|
2021
Q3 | $4K | Hold |
68
| – | – | ﹤0.01% | 395 |
|
|
2021
Q2 | $5K | Buy |
+68
| New | +$4.43K | ﹤0.01% | 346 |
|
|
2019
Q1 | – | Sell |
-26
| Closed | -$1K | – | 272 |
|
|
2018
Q4 | $1K | Sell |
26
-24
| -48% | -$1.29K | ﹤0.01% | 302 |
|
|
2018
Q3 | $3K | Sell |
50
-8
| -14% | -$475 | ﹤0.01% | 265 |
|
|
2018
Q2 | $3K | Sell |
58
-271,002
| -100% | -$14.6M | ﹤0.01% | 263 |
|
|
2018
Q1 | $17.1M | Sell |
271,060
-43,712
| -14% | -$2.81M | 0.82% | 58 |
|
|
2017
Q4 | $19.3M | Sell |
314,772
-3,854
| -1% | -$241K | 0.83% | 57 |
|
|
2017
Q3 | $20.3M | Sell |
318,626
-2,418
| -0.8% | -$141K | 0.92% | 51 |
|
|
2017
Q2 | $17.9M | Buy |
321,044
+320,944
| +320,944% | +$17.5M | 0.85% | 56 |
|
|
2017
Q1 | $5K | Hold |
100
| – | – | ﹤0.01% | 176 |
|
|
2016
Q4 | $6K | Sell |
100
-884
| -90% | -$48.3K | ﹤0.01% | 192 |
|
|
2016
Q3 | $53K | Buy |
984
+884
| +884% | +$56.8K | ﹤0.01% | 133 |
|
|
2016
Q2 | $7K | Hold |
100
| – | – | ﹤0.01% | 193 |
|
|
2016
Q1 | $6K | Buy |
+100
| New | +$6.31K | ﹤0.01% | 183 |
|
|
2014
Q4 | – | Sell |
-300
| Closed | -$15.4K | – | 193 |
|
|
2014
Q3 | $15.4K | Buy |
+300
| New | +$15K | ﹤0.01% | 158 |
|
Other funds holding BMY
Country Trust Bank's BMY Position: Q2 2026 in Review
Country Trust Bank held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 235 shares worth $13.5K. The position accounts for ﹤0.01% of the portfolio, ranked #321.
Country Trust Bank first reported a position in BMY in Q3 2014 and has held it in 26 quarters since. The position peaked at $20.3M in Q3 2017. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Country Trust Bank held 235 shares of Bristol-Myers Squibb worth $13.5K as of Q2 2026.
- Country Trust Bank left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up ﹤0.01% of Country Trust Bank's portfolio in Q2 2026, its #321 holding.
- Country Trust Bank first reported a position in Bristol-Myers Squibb in Q3 2014 and has held it in 26 quarters since.
- Country Trust Bank's Bristol-Myers Squibb position peaked at $20.3M in Q3 2017.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Country Trust Bank's 13F filing for Q2 2026, filed 15 Jul 2026.